Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pediatric Hematology/Oncology
Hemostasis
Questions discussed in this category
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
Assume the patient has infrequent bleeding events every few years, with use of FIX replacement for acute bleeds only.
1 Answer available
How do you treat factor XI deficient patients with surgery or trauma related bleeding?
Is there a factor XI goal that you target? Would you consider FVIIa products instead?
1 Answer available
How do you interpret a low VWF activity/antigen ratio, when both activity and antigen levels are above 50%?
E.g. Normal F8, VWF activity ~50%, VWF antigen ~100%, ratio 0.5 sent in a patient with positive bleeding history Is there any clinical significance t...
1 Answer available
Would you use PCC for clotting factor repletion in acute life threatening hemorrhage in a patient with elevated INR from coagulopathy of liver disease?
2 Answers available
When do you stop trying to eradicate an acquired factor VIII inhibitor?
Patient with high titer acquired FVIII inhibitor with no causative etiology. Bleeding is well-controlled on emicizumab, but inhibitor has failed...
3 Answers available
In patients with severe hemophilia A on emicizumab for prophylaxis, in case of noncompliance leading to a lapse of more than 2-3 months off therapy, do you reload with emicizumab?
1 Answer available
How would you manage VTE in a patient with bleeding disorder such as hemophilia?
Have you used anticoagulants other than coumadin? Or is that the only appropriate agent given monitoring is based on PT/INR?
1 Answer available
What additional testing, if any, should be performed for an adolescent patient with heavy menstrual bleeding and a negative von Willebrand disease evaluation?
1 Answer available
Are patients with bleeding disorders receiving plasma-derived products at increased risk of acquiring COVID-19?
1 Answer available
Should patients with bleeding disorders increase their home supplies of clotting factors foreseeing a possible shortage of product availability due to COVID-19?
1 Answer available
21635
20344
17898
15988
14069
13740
10855
9636
6999
6998
Papers discussed in this category
Haematologica, 2019 Oct 17
Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort.
J Thromb Haemost,
Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric/neonatal and women's health SSCs.
Blood, 2016-07-14
How I treat patients with inherited bleeding disorders who need anticoagulant therapy.
Blood, 2016 Sep 26
New concepts for anticoagulant therapy in persons with hemophilia.
Hematology. American Society of Hematology. Education Program, 2015
Coagulopathy in liver disease: a balancing act.
Related Topics in Pediatric Hematology/Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers